DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clindamycin phosphate 1% gel in acne vulgaris.

Author(s): Rizer RL, Sklar JL, Whiting D, Bucko A, Shavin J, Jarratt M

Affiliation(s): TJ Stephens & Associates, Colorado Springs, Colorado 80915, USA.

Publication date & source: 2001-11, Adv Ther., 18(6):244-52.

Publication type: Clinical Trial; Multicenter Study; Randomized Controlled Trial

A 12-week study compared Clindagel, a unique water-based gel formulation of clindamycin phosphate 1%, administered once daily, and Cleocin T, a slightly different gel formulation indicated for twice-daily use, in the treatment of acne vulgaris. Clindagel was safe and effective and equivalent to Cleocin T gel, albeit with a better tolerability profile. Clindagel is a viable alternative to Cleocin T gel.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017